Revvity (RVTY) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Revvity (RVTY) is Neutral.

The composite score behind that read is +0.03, weighing +0.14 of bullish evidence against -0.06 bearish.

Revvity last closed at $153.30, -2.58% on the session.

Against the IVW growth benchmark the position is -3.19% over the forecast window.

The read is built from 11 underlying insights — 4 bullish and 7 bearish.

Agreement across those insights is 36%.

Revvity has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Revvity in the 9th percentile on valuation and the 45th percentile on return on equity, where 100 is best.

Revvity is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $17.56B.

StockMap tracks Revvity as the 9th largest of the 40 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 33 Neutral, 6 Moderate Underperform and 1 Strong Underperform.

On that composite Revvity ranks 2nd of 40 in the group, against a group median of -0.08.